Weiden P L, Storb R, Tsoi M S, Graham T C, Lerner K G, Thomas E D
J Immunol. 1976 May;116(5):1212-9.
Canine radiation chimeras were used to investigate further mechanism(s) responsible for maintaining the stable chimeric state. Chimeras were studied 7 to 46 months after 1200 R total body irradiation and transplantation of marrow from a littermate donor matched at the major histocompatibility complex. An attempt was made to perturb the stable chimeric state by infusion of large numbers (0.6 to 13.7 x 10(8)/kg) of donor peripheral blood lymphocytes into each respective chimera. Two groups were studied: donors in Group A were normal; donors in Group B had been specifically sensitized against minor histocompatibility antigens of the chimera by repeated skin grafts. None of the nine chimeras in Group A developed significant clinical or histologic evidence of graft-vs-host disease (GVHD) after donor lymphocyte infusion. Eight of the 12 chimeras in Group B, however, developed GVHD which was transient in three and fatal in five. The results in Group A are not consistent with classical theories of tolerance, i.e., elimination or inactivation of potentially reactive cell clones, but suggest the presence of an active mechanism suppressing recognition of host antigens by the infused donor lymphocytes and development of GVHD. The results in Group B indicate that this mechanism can be overcome by infusion of sensitized donor cells. In an attempt to elucidate the nature of this postulated active mechanism, the cytotoxicity of donor lymphocytes for fibroblasts of the chimera and the presence or absence of serum-blocking factors were assessed in vitro by using a cellular inhibition (CI) assay. The presence of serum-blocking factors did not protect against the development of significant GVHD in two chimeras (fatal in one). GVHD did not occur in four other chimeras after infusion of cytotoxic donor lymphocytes despite the absence of serum-blocking factors. These and previous results suggest that serum-blocking factors are not the mechanisms suppressing the development of GVHD in canine radiation chimeras, and raise the possibility that a suppressor cell population may be responsible for preventing GVHD.
犬辐射嵌合体被用于进一步研究维持稳定嵌合状态的机制。在全身接受1200拉德照射并移植来自主要组织相容性复合体匹配的同窝供体的骨髓后7至46个月对嵌合体进行研究。尝试通过向每个相应的嵌合体输注大量(0.6至13.7×10⁸/kg)供体外周血淋巴细胞来扰乱稳定的嵌合状态。研究了两组:A组的供体是正常的;B组的供体通过反复皮肤移植对嵌合体的次要组织相容性抗原产生了特异性致敏。A组的9只嵌合体在输注供体淋巴细胞后均未出现移植物抗宿主病(GVHD)的显著临床或组织学证据。然而,B组的12只嵌合体中有8只发生了GVHD,其中3只呈短暂性,5只致死。A组的结果与经典的耐受理论不一致,即潜在反应性细胞克隆的消除或失活,而是提示存在一种活性机制,可抑制输注的供体淋巴细胞对宿主抗原的识别以及GVHD的发生。B组的结果表明,这种机制可通过输注致敏的供体细胞来克服。为了阐明这种假定的活性机制的性质,通过细胞抑制(CI)试验在体外评估了供体淋巴细胞对嵌合体成纤维细胞的细胞毒性以及血清阻断因子的有无。血清阻断因子的存在并不能防止两只嵌合体(其中一只致死)发生显著的GVHD。在输注具有细胞毒性的供体淋巴细胞后,另外四只嵌合体尽管没有血清阻断因子,但也未发生GVHD。这些结果以及之前的结果表明,血清阻断因子不是抑制犬辐射嵌合体中GVHD发生的机制,并增加了抑制性细胞群体可能负责预防GVHD的可能性。